The Prophylactic Effect of Stilamin on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- An Di Tian, Pro.
Tongji Hospital
Principal Investigator - Bing Hu, Pro.
Eastern Hepatobiliary Surgery Hospital
Principal Investigator - Chao Fa Zhi, Pro.
Nanfang Hospital, Southern Medical University
Principal Investigator - Feng Xi Zhang, Pro.
Hangzhou First People Hospital
Principal Investigator - Gang Xu Guo, Pro.
Xijing Hospital
Principal Investigator - Guo Zh Nie, Pro.
Wulumuqi General Hospital of Chinese PLA
Principal Investigator - Hua Lo Lu, Pro.
The First Affiliated Hospital of Nanchang University
Principal Investigator - Jian Xi Wan, Pro.
Shanghai First People Hospital
Principal Investigator - Ming Yi, Pro.
Beijing Friendship Hospital
Principal Investigator - Ping Bie, Pro.
xinan hospital
Principal Investigator - Ping Li He, Pro.
Fujian Province Hospital
Principal Investigator - Ping Xi Zhou, Pro.
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Principal Investigator - Shen Zh Li, Pro.
Changhai Hospital
Principal Investigator - Tang Sh Han, Pro.
Jiangsu Province of TCM
Principal Investigator - Xun Ren, Pro.
The People' Hospital of Heilongjiang Province
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Fujian Province Hospital
Fuzhou, Fujian, China
Active, not recruiting - Nanfang Hospital
Guangzhou, Guangdong, China
Active, not recruiting - the People' Hospital of Heilongjiang Province
Haerbin, Heilongjiang, China
Active, not recruiting - Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
Active, not recruiting - the First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Active, not recruiting - Xijing Hospital
Xi’an, Shanxi, China
Active, not recruiting - Wulumuqi General Hospital of Chinese Pla
Ürümqi, Xinjiang, China
Active, not recruiting - Hangzhou First People Hospital
Hangzhou, Zhejiang, China
Active, not recruiting - Beijing Friendship Hospital
Beijing, China
Active, not recruiting - Xinan Hospital
Chongqing, China
Active, not recruiting - Jiangsu Province of Tcm
Nanjing, China
Active, not recruiting - Changhai Hospital
Shanghai, China
Shen Zh Li, Pro.Recruiting - Eastern Hepatobiliary Surgery Hospital
Shanghai, China
Active, not recruiting - Shanghai First People Hospital
Shanghai, China
Active, not recruiting - Tongji Hospital
Wuhan, China
Active, not recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2011
- Primary completion
- 31 Dec 2012
- Completion
- 31 Mar 2013
- Last update posted
- 27 Sept 2011
- Registered enrollment
- 908
- Registry id
- NCT01431781
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.